What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation?

Antiplatelet Therapy ◽

Stent Implantation ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Optimal Duration ◽

Short- versus standard-term dual antiplatelet therapy after percutaneous coronary intervention with drug-eluting stent implantation: A meta-analysis

Journal of Cardiology ◽

10.1016/j.jjcc.2016.07.021 ◽

2017 ◽

Vol 69 (1) ◽

pp. 353-358 ◽

Cited By ~ 4

Author(s):

Jade E. Basaraba ◽

Arden R. Barry

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Meta Analysis ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Drug Eluting ◽

Standard Term

Optimum duration of dual antiplatelet therapy followed by monotherapy for diabetes after percutaneous coronary intervention with drug-eluting stent implantation: a Bayesian network meta-analysis

Polish Archives of Internal Medicine ◽

10.20452/pamw.16032 ◽

2021 ◽

Author(s):

Ke An ◽

Peng Guo ◽

Shanhu Qiu ◽

Wenwen Zhu ◽

Wuyou Cao ◽

...

Keyword(s):

Bayesian Network ◽

Antiplatelet Therapy ◽

Stent Implantation ◽

Meta Analysis ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention with Drug-Eluting Stent Implantation: A Review of the Current Guidelines and Literature

Hospital Practice ◽

10.3810/hp.2011.10.920 ◽

2011 ◽

Vol 39 (4) ◽

pp. 32-40 ◽

Cited By ~ 7

Author(s):

Gilles Lemesle ◽

Francesco Paparoni ◽

Cedric Delhaye ◽

Laurent Bonello ◽

Jean-Marc Lablanche

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Drug Eluting ◽

Current Guidelines

Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation Treated With Short Dual Antiplatelet Therapy: A Recre8 Subanalysis

Cardiovascular Revascularization Medicine ◽

10.1016/j.carrev.2021.06.048 ◽

2021 ◽

Vol 28 ◽

pp. S20-S21

Author(s):

Nicole D. van Hemert ◽

Michiel Voskuil ◽

Rik Rozemeijer ◽

Mèra Stein ◽

Peter Frambach ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Stent Implantation ◽

Bleeding Risk ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

Drug Eluting ◽

High Bleeding Risk

The optimal duration of dual antiplatelet therapy in patients receiving percutaneous coronary intervention with drug-eluting stents

Cardiology Journal ◽

10.5603/cj.a2015.0078 ◽

2016 ◽

Vol 23 (3) ◽

pp. 307-316 ◽

Cited By ~ 4

Author(s):

Olusegun Sheyin ◽

Xavier Perez ◽

Bredy Pierre-Louis ◽

Damian Kurian

Keyword(s):

Antiplatelet Therapy ◽

Coronary Intervention ◽

Drug Eluting Stents ◽

Percutaneous Coronary ◽

Optimal Duration ◽

Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial

American Heart Journal ◽

10.1016/j.ahj.2017.02.015 ◽

2017 ◽

Vol 187 ◽

pp. 104-111 ◽

Cited By ~ 6

Author(s):

Miguel E. Lemmert ◽

Keith Oldroyd ◽

Paul Barragan ◽

Maciej Lesiak ◽

Robert A. Byrne ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Study Design ◽

Real World ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Left Main ◽

Percutaneous Coronary ◽

CRT-100.59 Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Drug-Eluting Stent Implantation — Meta-Analysis of Randomized Controlled Trials

JACC Cardiovascular Interventions ◽

10.1016/j.jcin.2020.01.042 ◽

2020 ◽

Vol 13 (4) ◽

pp. S15

Author(s):

Muhammad Faisal Khalid ◽

Abdul Ahad Khan ◽

Ghulam Murtaza ◽

Timir K. Paul

Keyword(s):

Stent Implantation ◽

Meta Analysis ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Controlled Trials ◽

Randomized Controlled ◽

Percutaneous Coronary ◽

Cost-effectiveness analysis of short-duration dual antiplatelet therapy with newer drug-eluting stent platforms versus longer-duration dual antiplatelet therapy with a second-generation drug-eluting stent in elective percutaneous coronary intervention

Coronary Artery Disease ◽

10.1097/mca.0000000000000694 ◽

2019 ◽

Vol 30 (3) ◽

pp. 177-182

Author(s):

Benjamin Z. Galper ◽

Matthew R. Reynolds ◽

Pallav Garg ◽

Eric A. Secemsky ◽

Linda R. Valsdottir ◽

...

Keyword(s):

Cost Effectiveness ◽

Antiplatelet Therapy ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Elective Percutaneous Coronary Intervention ◽

Effectiveness Analysis ◽

Percutaneous Coronary ◽

P2680Long-term prognosis after dual antiplatelet therapy in hemodialysis patients following percutaneous coronary intervention with second-generation drug eluting stent

European Heart Journal ◽

10.1093/eurheartj/ehy565.p2680 ◽

2018 ◽

Vol 39 (suppl_1) ◽

Author(s):

A Shimizu ◽

S Sonoda ◽

T Miura ◽

H Takami ◽

R Anai ◽

...

Keyword(s):

Antiplatelet Therapy ◽

Second Generation ◽

Coronary Intervention ◽

Hemodialysis Patients ◽

Drug Eluting Stent ◽

Percutaneous Coronary ◽

What Is the Optimal Dual Antiplatelet Therapy Strategy After Percutaneous Coronary Intervention in the Era of New-Generation Drug-Eluting Stent?

Circulation Journal ◽

10.1253/circj.cj-20-0658 ◽

2020 ◽

Vol 84 (9) ◽

pp. 1459-1460

Author(s):

Hiroaki Yokoyama

Keyword(s):

Antiplatelet Therapy ◽

Coronary Intervention ◽

Drug Eluting Stent ◽

Therapy Strategy ◽

Percutaneous Coronary ◽

Drug Eluting ◽

New Generation